It is a pharma private limited company based in Delhi, Delhi, India, established in 2013.
2013 | Delhi, Delhi, India | ActiveMedora Pharmaceutical Private Limited, a active private limited company, was established on 04 March 2013 in Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U51397DL2013PTC249013. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Rakesh Kumar (Additional Director), Rameshsingh Harisingh Thakur (Additional Director), Anil Tribhuvan Vishwakarma (Additional Director). Past directors included Geeta Singhal, Rakesh Dhawan, Anju Verma. Its latest AGM occurred on 23 September 2024, with the balance sheet filed on 31 March 2024. It is based at 47-A, Vishwakarma Park Laxmi Nagar, Delhi, Delhi, 110092.
U51397DL2013PTC249013
249013
04 March 2013
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Medora Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rakesh Kumar | Additional Director | 24 Dec 2024 | Current |
| Rameshsingh Harisingh Thakur | Additional Director | 24 Dec 2024 | Current |
| Anil Tribhuvan Vishwakarma | Additional Director | 24 Dec 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 22 Dec 2017 | Past |
| Pramod Abcsdd | Director | 03 Nov 2016 | Past |
| Pramod Abcsdd | Director | 25 Nov 2013 | Past |
| Pramod Abcsdd | Additional Director | 20 Nov 2020 | Past |
| Pramod Abcsdd | Director | 06 Jul 2022 | Past |
| Pramod Abcsdd | Additional Director | 23 Sep 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Medora Pharmaceutical Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 7.74% increase in profit. The company's net worth observed a substantial decline by a decrease of 44.57%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Medora Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Medora Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Medora Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medora Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Rakesh Kumar was appointed as a Additional Director was appointed as a Additional Director on 24 Dec 2024 & has been associated with this company since 11 months 1 day . was completed.
Progress on Rameshsingh Harisingh Thakur was appointed as a Additional Director was appointed as a Additional Director on 24 Dec 2024 & has been associated with this company since 11 months 1 day . was documented.
Progress on Anil Tribhuvan Vishwakarma was appointed as a Additional Director was appointed as a Additional Director on 24 Dec 2024 & has been associated with this company since 11 months 1 day . was documented.
Progress on Medora Pharmaceutical Private Limited last Annual general meeting of members was held on 23 Sep 2024 as per latest MCA records. was documented.
Medora Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
Progress on Medora Pharmaceutical Private Limited was registered on 04 Mar 2013 with Roc Delhi & aged 12 years 8 months as per MCA records. was documented.
The CIN of Medora Pharmaceutical Private Limited is U51397DL2013PTC249013.
Medora Pharmaceutical Private Limited is headquartered at 47-A, Vishwakarma Park Laxmi Nagar, Delhi, Delhi, 110092.
Medora Pharmaceutical Private Limited was incorporated on 04 March 2013.
The current directors of Medora Pharmaceutical Private Limited are
The primary industry of Medora Pharmaceutical Private Limited is Trade.
Medora Pharmaceutical Private Limited is unlisted.
The authorized capital of Medora Pharmaceutical Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Medora Pharmaceutical Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX